Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Enterprise value to sales ratio

Percentile
P0
Near historical low
vs 5Y Ago
-3.7x
Contraction
Streak
3 yr
Consecutive declineCompressed
PeriodValueYoY Change
2024-166.86-7278.8%
2023-2.26-175.3%
20223.00-89.6%
202128.89+10.3%
202026.19-42.0%
201945.13+606.7%
20186.39+214.7%
20172.03-53.2%
20164.33-
20150.00-